Demyelinating Changes Alike to Multiple Sclerosis: A Case Report of Rare Manifestations of COVID-19
Fatemeh Yavari, Sara Raji, Fatemeh Moradi, Morteza Saeidi
Abstract
COVID-19, as a global concern and pivotal issue in the healthcare system, could have various presentations, leading to difficulty in diagnosis and management. Neuroinvasive potency, as claimed by preliminary studies, is a considerable pathogenesis. Serious neurological disorders like multiple sclerosis (MS) were out of the blue to be the first demonstration of COVID-19. This report highlights the representation of MS in a young woman, which resulted in a COVID-19 diagnosis.
Topics & Concepts
MedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Demyelinating DisorderIntensive care medicinePsychiatryPathologyDiseaseOutbreakInfectious disease (medical specialty)Long-Term Effects of COVID-19Multiple Sclerosis Research StudiesCOVID-19 Clinical Research Studies